BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24757095)

  • 1. Paget's disease of bone.
    Tan A; Ralston SH
    QJM; 2014 Nov; 107(11):865-9. PubMed ID: 24757095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paget's disease: a clinical review.
    Shah M; Shahid F; Chakravarty K
    Br J Hosp Med (Lond); 2015 Jan; 76(1):25-30. PubMed ID: 25585180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of Paget's disease of bone.
    Ralston SH
    Bone; 2008 Nov; 43(5):819-25. PubMed ID: 18672105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of Paget's disease of bone.
    Ralston SH; Albagha OM
    Curr Osteoporos Rep; 2014 Sep; 12(3):263-71. PubMed ID: 24988994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zoledronate in the prevention of Paget's (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent
    Cronin O; Forsyth L; Goodman K; Lewis SC; Keerie C; Walker A; Porteous M; Cetnarskyj R; Ranganath LR; Selby PL; Hampson G; Chandra R; Ho S; Tobias JH; Young-Min S; McKenna MJ; Crowley RK; Fraser WD; Gennari L; Nuti R; Brandi ML; Del Pino-Montes J; Devogelaer JP; Durnez A; Isaia G; Di Stefano M; GuaƱabens N; Blanch J; Seibel MJ; Walsh JP; Kotowicz MA; Nicholson GC; Duncan EL; Major G; Horne A; Gilchrist NL; Boers M; Murray GD; Charnock K; Wilkinson D; Russell RGG; Ralston SH
    BMJ Open; 2019 Sep; 9(9):e030689. PubMed ID: 31488492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Paget's disease of bone: new therapeutic strategies].
    D'Amore M; Lisi S; Sisto M; De Marino AV
    Recenti Prog Med; 2013 Mar; 104(3):89-92. PubMed ID: 23548950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sporadic hyperphosphatasia syndrome featuring periostitis and accelerated skeletal turnover without receptor activator of nuclear factor-kappaB, osteoprotegerin, or sequestosome-1 gene defects.
    Simsek S; Basoski NM; Bravenboer N; Zhang X; Mumm S; Whyte MP; Netelenbos JC
    J Clin Endocrinol Metab; 2007 May; 92(5):1897-901. PubMed ID: 17284635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biology and Treatment of Paget's Disease of Bone.
    Vallet M; Ralston SH
    J Cell Biochem; 2016 Feb; 117(2):289-99. PubMed ID: 26212817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology and genetics of metabolic bone disorders characterized by increased bone turnover.
    Beyens G; Van Hul W
    Crit Rev Eukaryot Gene Expr; 2007; 17(3):215-40. PubMed ID: 17725490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Paget's disease of bone].
    Takata S
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():219-25. PubMed ID: 16279635
    [No Abstract]   [Full Text] [Related]  

  • 11. Paget's disease: epidemiology and pathophysiology.
    Seton M
    Curr Osteoporos Rep; 2008 Dec; 6(4):125-9. PubMed ID: 19032921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etiologic factors in Paget's disease of bone.
    Reddy SV
    Cell Mol Life Sci; 2006 Feb; 63(4):391-8. PubMed ID: 16429324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis and management of Paget's disease of bone.
    Ralston SH; Langston AL; Reid IR
    Lancet; 2008 Jul; 372(9633):155-163. PubMed ID: 18620951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paget's disease of bone: 1877-2023. Etiology, and management of a disease on epidemiologic transition.
    Corral Gudino L
    Med Clin (Barc); 2023 Sep; 161(5):207-216. PubMed ID: 37263846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation screening of the TNFRSF11A gene encoding receptor activator of NF kappa B (RANK) in familial and sporadic Paget's disease of bone and osteosarcoma.
    Sparks AB; Peterson SN; Bell C; Loftus BJ; Hocking L; Cahill DP; Frassica FJ; Streeten EA; Levine MA; Fraser CM; Adams MD; Broder S; Venter JC; Kinzler KW; Vogelstein B; Ralston SH
    Calcif Tissue Int; 2001 Mar; 68(3):151-5. PubMed ID: 11351498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paget's disease of bone.
    Cundy T
    Metabolism; 2018 Mar; 80():5-14. PubMed ID: 28780255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone turnover markers in Paget's disease of the bone: A Systematic review and meta-analysis.
    Al Nofal AA; Altayar O; BenKhadra K; Qasim Agha OQ; Asi N; Nabhan M; Prokop LJ; Tebben P; Murad MH
    Osteoporos Int; 2015 Jul; 26(7):1875-91. PubMed ID: 26037791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the role of sequestosome 1/p62 mutant proteins in the pathogenesis of Paget's disease of bone.
    Rea SL; Walsh JP; Layfield R; Ratajczak T; Xu J
    Endocr Rev; 2013 Aug; 34(4):501-24. PubMed ID: 23612225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The current status of Paget's disease of the bone.
    Keen RW
    Hosp Med; 2003 Apr; 64(4):230-2. PubMed ID: 12731136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of disease: genetics of Paget's disease of bone and related disorders.
    Daroszewska A; Ralston SH
    Nat Clin Pract Rheumatol; 2006 May; 2(5):270-7. PubMed ID: 16932700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.